Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Lourdes
Vázquez López
Publications dans lesquelles il/elle collabore avec Lourdes Vázquez López (55)
2022
-
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Microbiology Spectrum, Vol. 10, Núm. 3
-
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550
2020
-
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Experimental Hematology and Oncology, Vol. 9, Núm. 1
2013
-
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Haematologica, Vol. 98, Núm. 3, pp. 437-443
2011
-
Effect of vitamin D treatment in chronic GVHD
Bone Marrow Transplantation
-
Invasive fungal infections in onco-haematology: A spanish perspective
Revista Espanola de Quimioterapia, Vol. 24, Núm. 3, pp. 168-172
-
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica
2010
-
Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant
American Journal of Hematology, Vol. 85, Núm. 4, pp. 290-293
-
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma
European Journal of Haematology, Vol. 84, Núm. 3, pp. 266-270
2009
-
Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, Vol. 15, Núm. 10, pp. 1331-1336
2008
-
Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy
Biology of Blood and Marrow Transplantation, Vol. 14, Núm. 10, pp. 1163-1171
-
Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain
Medicina Clinica, Vol. 131, Núm. 12, pp. 441-446
-
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study
Haematologica, Vol. 93, Núm. 12, pp. 1829-1836
2006
-
Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Acute Graft-versus-Host Disease (GVHD)
Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 9, pp. 936-941
-
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients [14]
Leukemia
-
Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy [5]
Bone Marrow Transplantation
2005
-
CD34+ cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
Leukemia and Lymphoma, Vol. 46, Núm. 2, pp. 177-183
-
Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma
Haematologica, Vol. 90, Núm. 1, pp. 78-85
-
Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia
Leukemia, Vol. 19, Núm. 3, pp. 402-409
-
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors
Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 5, pp. 354-361